0001213900-21-038634.txt : 20210726 0001213900-21-038634.hdr.sgml : 20210726 20210726161521 ACCESSION NUMBER: 0001213900-21-038634 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210715 FILED AS OF DATE: 20210726 DATE AS OF CHANGE: 20210726 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Townsend John CENTRAL INDEX KEY: 0001511906 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40582 FILM NUMBER: 211114309 MAIL ADDRESS: STREET 1: 15150 AVENUE OF SCIENCE STREET 2: SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92128 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Unicycive Therapeutics, Inc. CENTRAL INDEX KEY: 0001766140 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 813638692 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5150 EL CAMINO REAL, SUITE A-32 CITY: LOS ALTOS STATE: CA ZIP: 94022 BUSINESS PHONE: 650-384-0642 MAIL ADDRESS: STREET 1: 5150 EL CAMINO REAL, SUITE A-32 CITY: LOS ALTOS STATE: CA ZIP: 94022 4 1 ownership.xml OWNERSHIP DOCUMENT X0306 4 2021-07-15 0 0001766140 Unicycive Therapeutics, Inc. UNCY 0001511906 Townsend John C/O UNICYCIVE THERAPEUTICS LOS ALTOS CA 94022 0 1 0 0 Chief Financial Officer Stock Options 5.00 2021-07-15 4 A 0 18605 0 A 2031-07-15 Common Stock 18605 41861 D The stock options vest equally over a period of three years from the date of grant. /s/ John Townsend 2021-07-26